表紙
市場調査レポート

北米における心調律管理装置市場の見通し

North America Cardiac Rhythm Management Market Outlook to 2020

発行 GlobalData 商品コード 304021
出版日 ページ情報 英文 208 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
北米における心調律管理装置市場の見通し North America Cardiac Rhythm Management Market Outlook to 2020
出版日: 2014年05月16日 ページ情報: 英文 208 Pages
概要

当レポートでは、北米における心調律管理装置市場について、心臓再同期療法用装置(除細動器およびペースメーカー)、埋込型心臓除細動器、埋込型心電図記録計、ペースメーカーのカテゴリー別売上、販売数の実績および予測、平均価格、企業シェア、流通シェア、主要企業のプロファイル、パイプライン製品、主な財務取引についての最新情報などを提供しまとめており、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

  • レポートの内容
  • 心調律管理装置装置市場の区分
  • 本レポートで対象としている市場の定義

第3章 北米における心調律管理装置市場

  • 収益(実績・予測)
  • 収益別カテゴリー比較(実績・予測)
  • 収益(実績)
  • 収益(予測)
  • 販売数(実績・予測)
  • 販売数(実績)
  • 販売数(予測)
  • 企業シェア:収益別

第4章 カナダにおける心調律管理装置市場

  • 収益(実績)
  • 収益(予測)
  • 販売数(実績)
  • 販売数(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第5章 メキシコにおける心調律管理装置市場

  • 収益(実績)
  • 収益(予測)
  • 販売数(実績)
  • 販売数(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第6章 米国における心調律管理装置市場

  • 収益(実績)
  • 収益(予測)
  • 販売数(実績)
  • 販売数(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第7章 主要企業の概要

  • Medtronic, Inc.
  • St. Jude Medical, Inc.
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Sorin S.p.A.

第8章 パイプライン製品

第9章 最新の動向

  • コーポレート・コミュニケーション
  • 財務発表
  • 政府・公益関連情報
  • 法規制
  • 他の重要な動向
  • 製品情報
  • 戦略および事業企画

第10章 付録

図表

目次
Product Code: GDMECR0090DB

GlobalData's new report, "North America Cardiac Rhythm Management Market Outlook to 2020", provides key market data on the North America Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Resynchronisation Therapy (Defibrillators and Pacemakers), Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiac Rhythm Management Market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Cardiac Rhythm Management Devices categories - Cardiac Resynchronisation Therapy, Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers.
  • Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
  • 2012 company shares and distribution shares data for the market category.
  • Global corporate-level profiles of key companies operating within the North America Cardiac Rhythm Management Devices market.
  • Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Boston Scientific Corporation and BIOTRONIK SE & Co. KG.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Cardiac Rhythm Management Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Cardiac Rhythm Management Market, North America

  • 3.1. Cardiac Rhythm Management Market, North America, Revenue ($m), 2005-2020
  • 3.2. Cardiac Rhythm Management Market, North America, Category Comparison by Revenue ($m), 2005-2020
  • 3.3. Cardiac Rhythm Management Market, North America, Revenue ($m), 2005-2012
  • 3.4. Cardiac Rhythm Management Market, North America, Revenue ($m), 2012-2020
  • 3.5. Cardiac Rhythm Management Market, North America, Volume (Units), 2005-2020
  • 3.6. Cardiac Rhythm Management Market, North America, Volume (Units), 2005-2012
  • 3.7. Cardiac Rhythm Management Market, North America, Volume (Units), 2012-2020
  • 3.8. Cardiac Rhythm Management Market, North America, Company Share by Revenue ($m), 2011-2012

4. Cardiac Rhythm Management Market, Canada

  • 4.1. Cardiac Rhythm Management Market, Canada, Revenue ($m), 2005-2012
  • 4.2. Cardiac Rhythm Management Market, Canada, Revenue ($m), 2012-2020
    • 4.2.1. Cardiac Resynchronisation Therapy Market, Canada, Revenue ($m), by Segment, 2005-2012
    • 4.2.2. Implantable Cardioverter Defibrillators Market, Canada, Revenue ($m), by Segment, 2005-2012
    • 4.2.3. Pacemakers Market, Canada, Revenue ($m), by Segment, 2005-2012
    • 4.2.4. Cardiac Resynchronisation Therapy Market, Canada, Revenue ($m), by Segment, 2012-2020
    • 4.2.5. Implantable Cardioverter Defibrillators Market, Canada, Revenue ($m), by Segment, 2012-2020
    • 4.2.6. Pacemakers Market, Canada, Revenue ($m), by Segment, 2012-2020
  • 4.3. Cardiac Rhythm Management Market, Canada, Volume (Units), 2005-2012
  • 4.4. Cardiac Rhythm Management Market, Canada, Volume (Units), 2012-2020
    • 4.4.1. Cardiac Resynchronisation Therapy Market, Canada, Volume (Units), by Segment, 2005-2012
    • 4.4.2. Implantable Cardioverter Defibrillators Market, Canada, Volume (Units), by Segment, 2005-2012
    • 4.4.3. Pacemakers Market, Canada, Volume (Units), by Segment, 2005-2012
    • 4.4.4. Cardiac Resynchronisation Therapy Market, Canada, Volume (Units), by Segment, 2012-2020
    • 4.4.5. Implantable Cardioverter Defibrillators Market, Canada, Volume (Units), by Segment, 2012-2020
    • 4.4.6. Pacemakers Market, Canada, Volume (Units), by Segment, 2012-2020
  • 4.5. Cardiac Rhythm Management Market, Canada, Average Price ($), 2005-2020
  • 4.6. Cardiac Rhythm Management Market, Canada, Distribution Share by Revenue ($m), 2011-2012
  • 4.7. Cardiac Rhythm Management Market, Canada, Company Share by Revenue ($m), 2011-2012

5. Cardiac Rhythm Management Market, Mexico

  • 5.1. Cardiac Rhythm Management Market, Mexico, Revenue ($m), 2005-2012
  • 5.2. Cardiac Rhythm Management Market, Mexico, Revenue ($m), 2012-2020
    • 5.2.1. Cardiac Resynchronisation Therapy Market, Mexico, Revenue ($m), by Segment, 2005-2012
    • 5.2.2. Implantable Cardioverter Defibrillators Market, Mexico, Revenue ($m), by Segment, 2005-2012
    • 5.2.3. Pacemakers Market, Mexico, Revenue ($m), by Segment, 2005-2012
    • 5.2.4. Cardiac Resynchronisation Therapy Market, Mexico, Revenue ($m), by Segment, 2012-2020
    • 5.2.5. Implantable Cardioverter Defibrillators Market, Mexico, Revenue ($m), by Segment, 2012-2020
    • 5.2.6. Pacemakers Market, Mexico, Revenue ($m), by Segment, 2012-2020
  • 5.3. Cardiac Rhythm Management Market, Mexico, Volume (Units), 2005-2012
  • 5.4. Cardiac Rhythm Management Market, Mexico, Volume (Units), 2012-2020
    • 5.4.1. Cardiac Resynchronisation Therapy Market, Mexico, Volume (Units), by Segment, 2005-2012
    • 5.4.2. Implantable Cardioverter Defibrillators Market, Mexico, Volume (Units), by Segment, 2005-2012
    • 5.4.3. Pacemakers Market, Mexico, Volume (Units), by Segment, 2005-2012
    • 5.4.4. Cardiac Resynchronisation Therapy Market, Mexico, Volume (Units), by Segment, 2012-2020
    • 5.4.5. Implantable Cardioverter Defibrillators Market, Mexico, Volume (Units), by Segment, 2012-2020
    • 5.4.6. Pacemakers Market, Mexico, Volume (Units), by Segment, 2012-2020
  • 5.5. Cardiac Rhythm Management Market, Mexico, Average Price ($), 2005-2020
  • 5.6. Cardiac Rhythm Management Market, Mexico, Distribution Share by Revenue ($m), 2011-2012
  • 5.7. Cardiac Rhythm Management Market, Mexico, Company Share by Revenue ($m), 2011-2012

6. Cardiac Rhythm Management Market, United States

  • 6.1. Cardiac Rhythm Management Market, United States, Revenue ($m), 2005-2012
  • 6.2. Cardiac Rhythm Management Market, United States, Revenue ($m), 2012-2020
    • 6.2.1. Cardiac Resynchronisation Therapy Market, United States, Revenue ($m), by Segment, 2005-2012
    • 6.2.2. Implantable Cardioverter Defibrillators Market, United States, Revenue ($m), by Segment, 2005-2012
    • 6.2.3. Pacemakers Market, United States, Revenue ($m), by Segment, 2005-2012
    • 6.2.4. Cardiac Resynchronisation Therapy Market, United States, Revenue ($m), by Segment, 2012-2020
    • 6.2.5. Implantable Cardioverter Defibrillators Market, United States, Revenue ($m), by Segment, 2012-2020
    • 6.2.6. Pacemakers Market, United States, Revenue ($m), by Segment, 2012-2020
  • 6.3. Cardiac Rhythm Management Market, United States, Volume (Units), 2005-2012
  • 6.4. Cardiac Rhythm Management Market, United States, Volume (Units), 2012-2020
    • 6.4.1. Cardiac Resynchronisation Therapy Market, United States, Volume (Units), by Segment, 2005-2012
    • 6.4.2. Implantable Cardioverter Defibrillators Market, United States, Volume (Units), by Segment, 2005-2012
    • 6.4.3. Pacemakers Market, United States, Volume (Units), by Segment, 2005-2012
    • 6.4.4. Cardiac Resynchronisation Therapy Market, United States, Volume (Units), by Segment, 2012-2020
    • 6.4.5. Implantable Cardioverter Defibrillators Market, United States, Volume (Units), by Segment, 2012-2020
    • 6.4.6. Pacemakers Market, United States, Volume (Units), by Segment, 2012-2020
  • 6.5. Cardiac Rhythm Management Market, United States, Average Price ($), 2005-2020
  • 6.6. Cardiac Rhythm Management Market, United States, Distribution Share by Revenue ($m), 2011-2012
  • 6.7. Cardiac Rhythm Management Market, United States, Company Share by Revenue ($m), 2011-2012

7. Overview of Key Companies in North America Cardiac Rhythm Management Market

  • 7.1. Medtronic, Inc.
    • 7.1.1. Company Overview
  • 7.2. St. Jude Medical, Inc.
    • 7.2.1. Company Overview
  • 7.3. Boston Scientific Corporation
    • 7.3.1. Company Overview
  • 7.4. Biotronik SE & Co. KG
    • 7.4.1. Company Overview
  • 7.5. Sorin S.p.A.
    • 7.5.1. Company Overview

8. Cardiac Rhythm Management Market Pipeline Products

9. Recent Developments

  • 9.1. Corporate Communications
    • 9.1.1. Apr 16, 2014: Proteus Digital Health Grows Leadership Team and Board of Directors with Former Executives from Novartis, Microsoft and Egreetings Network
    • 9.1.2. Apr 08, 2014: Ventripoint Corporate Update and Resignation of Director
    • 9.1.3. Feb 18, 2014: SurModics Announces Changes to Board of Directors
    • 9.1.4. Feb 14, 2014: Stereotaxis Appoints William C. Mills III to Chief Executive Officer
    • 9.1.5. Jan 06, 2014: Catalyst Pharmaceutical Partners Reports Successful Completion of Type B Breakthrough Therapy Meeting With FDA on Firdapse Tablets Development Program
    • 9.1.6. Dec 05, 2013: Anxious Patient Group Calls on NICE to Approve Only Drug Treatment for Ultra-Rare Disease
    • 9.1.7. Nov 04, 2013: Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R as a Potential Treatment for Spasticity in Multiple Sclerosis
    • 9.1.8. Sep 25, 2013: Accellent Announces the Promotion of Jeremy Friedman to President and Chief Operating Officer for the Cardio & Vascular Business and the Appointment of Richard Johnson as Interim CFO
    • 9.1.9. Sep 20, 2013: SurModics Announces Board Changes
    • 9.1.10. Sep 16, 2013: Arena Pharmaceuticals Provides Update as Eisai's Launch of BELVIQ CIV Enters Consumer Phase
    • 9.1.11. Aug 19, 2013: Orthofix Receives Expected NASDAQ Notice Related to Late Filing of Form 10-Q
    • 9.1.12. Aug 16, 2013: Stereotaxis Announces Listing Transfer to NASDAQ Capital Market
    • 9.1.13. Aug 02, 2013: China CDC Enters Into R&D Agreement With Aeras Global For TB Vaccine
    • 9.1.14. Jul 23, 2013: Dean Schauer, Executive Vice President, Cardio & Vascular Group, Announces Resignation
    • 9.1.15. Jul 02, 2013: InSite Vision Receives Notice of Allowance from USPTO for Patent on DuraSite 2 Ophthalmic Drug Delivery System
  • 9.2. Financial Announcements
    • 9.2.1. May 06, 2014: Stereotaxis Reports 2014 First Quarter Financial Results
    • 9.2.2. May 01, 2014: SurModics Reports Second Quarter Fiscal 2014 Results
    • 9.2.3. Apr 22, 2014: Bard Announces First Quarter Results
    • 9.2.4. Feb 25, 2014: Stereotaxis Reports 2013 Fourth Quarter and Full Year Financial Results
    • 9.2.5. Feb 18, 2014: Medtronic Reports Third Quarter Earnings
    • 9.2.6. Jan 30, 2014: Bard Announces Fourth Quarter Results
    • 9.2.7. Jan 30, 2014: SurModics Reports First Quarter Fiscal 2014 Results
    • 9.2.8. Dec 11, 2013: Bard Declares Quarterly Dividend
    • 9.2.9. Nov 19, 2013: Medtronic Reports Second Quarter Earnings
    • 9.2.10. Nov 14, 2013: Stereotaxis Reports Third Quarter 2013 Financial Results
    • 9.2.11. Nov 11, 2013: Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2014
    • 9.2.12. Nov 07, 2013: Accellent Announces Third Quarter 2013 Results
    • 9.2.13. Nov 05, 2013: SurModics Reports Fourth Quarter and Full Year 2013 Results
    • 9.2.14. Oct 29, 2013: SurModics to Webcast Fourth Quarter and Fiscal Year 2013 Earnings Conference Call on November 5
    • 9.2.15. Oct 23, 2013: Stereotaxis Announces Preliminary Third Quarter 2013 Financial Results in Preparation for Rights Offering
    • 9.2.16. Oct 22, 2013: Bard Announces Third Quarter Results
    • 9.2.17. Oct 09, 2013: Bard Declares Quarterly Dividend
    • 9.2.18. Oct 01, 2013: Bard to Host Earnings Conference Call on October 22, 2013
    • 9.2.19. Aug 20, 2013: Medtronic Reports First Quarter Earnings
    • 9.2.20. Aug 13, 2013: Accellent Announces Second Quarter 2013 Results
    • 9.2.21. Aug 12, 2013: Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2014
    • 9.2.22. Aug 08, 2013: Stereotaxis Reports Second Quarter 2013 Financial Results; Announces Capital Transactions
    • 9.2.23. Aug 06, 2013: Accellent Announces Timing of Second Quarter 2013 Earnings Release and Conference Call
    • 9.2.24. Jul 31, 2013: SurModics Reports Third Quarter Fiscal 2013 Results
    • 9.2.25. Jul 24, 2013: Bard Announces Second Quarter Results
    • 9.2.26. Jul 23, 2013: SurModics to Webcast Third Quarter 2013 Earnings Conference Call on July 31
    • 9.2.27. May 21, 2013: Medtronic Reports Revenue Of $16.6 Billion In Fiscal 2013
    • 9.2.28. May 14, 2013: Accellent Reports Revenue Of $120.8m In Q1 2013
  • 9.3. Government and Public Interest
    • 9.3.1. Jan 06, 2014: Medtronic CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference
    • 9.3.2. Jan 06, 2014: Bard to Host Earnings Conference Call on January 30, 2014
    • 9.3.3. Dec 20, 2013: Bard to Present at J.P. Morgan Healthcare Conference
    • 9.3.4. Dec 06, 2013: Stereotaxis to Present at Oppenheimer 24th Annual Healthcare Conference in New York on December 11, 2013
    • 9.3.5. Dec 04, 2013: SurModics to Present at Oppenheimer Healthcare Conference
    • 9.3.6. Dec 04, 2013: Medtronic CFO Gary Ellis to Speak at Oppenheimer Healthcare Conference
    • 9.3.7. Nov 26, 2013: SurModics to Present at Piper Jaffray Healthcare Conference
    • 9.3.8. Nov 26, 2013: Medtronic EVP & President Mike Coyle to Speak at Piper Jaffray Healthcare Conference
  • 9.4. Legal And Regulatory
    • 9.4.1. Apr 11, 2014: Federal Court Orders Preliminary Injunction on U.S. Sales of Medtronic's Infringing Transcatheter Valve
    • 9.4.2. Mar 12, 2014: Venaxis to Discuss Top-Line Results from Pivotal Study of APPY1 Test
    • 9.4.3. Jan 22, 2014: Medtronic Statement on U.S. Supreme Court Ruling in Medtronic, Inc. v. Mirowski Family Ventures
    • 9.4.4. Oct 19, 2013: Medtronic Statement on Medical Device Security
    • 9.4.5. Aug 16, 2013: Glancy Binkow & Goldberg Announces Class Action Lawsuit Against Orthofix International
    • 9.4.6. Aug 01, 2013: Medtronic Notifies More Than 2,700 Patients Of Lost Records
    • 9.4.7. Jul 01, 2013: Bronstein, Gewirtz & Grossman, LLC Announces that a Securities Class Action has been Filed Against Medtronic, Inc.
  • 9.5. Other Significant Developments
    • 9.5.1. Apr 16, 2014: Bard Declares Quarterly Dividend
    • 9.5.2. Feb 13, 2014: Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2014
    • 9.5.3. Jan 28, 2014: Medtronic Relocates Its Regional Headquarters to Dubai
    • 9.5.4. Jan 08, 2014: BIOTRONIK Devices and Leads, including latest DX System Technology, Now Available for Veterans Affairs Clients
    • 9.5.5. Dec 04, 2013: Medtronic Issues $500,000 in Health Access Grants to Support Diabetes Services for the Underserved of Greater Los Angeles
    • 9.5.6. Nov 27, 2013: Stereotaxis announces results of rights offering
    • 9.5.7. Sep 03, 2013: SurModics Announces Organizational Changes
    • 9.5.8. Aug 22, 2013: Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2014
    • 9.5.9. Jul 22, 2013: SurModics to Present at the InvestMNt Conference
  • 9.6. Product News
    • 9.6.1. Feb 13, 2014: New Data Support Use of iRhythm's ZIO Service to Identify Cardiac Arrhythmias in Stroke and TIA Patients
    • 9.6.2. Jan 27, 2014: Laerdal Medical and Wolters Kluwer Health Introduce Virtual Simulation Learning Tool for Nursing Students
    • 9.6.3. Jan 02, 2014: ZIO Service Identifies Significantly More Cardiac Arrhythmias Than the Traditional Holter Monitor, According to Study Published Online in the American Journal of Medicine
    • 9.6.4. Dec 20, 2013: First-in-Man Implantation of CARMAT's Bioprosthetic Artificial Heart
    • 9.6.5. Nov 15, 2013: FDA Classifies Medtronic's Worldwide Voluntary Field Action on Guidewires as Class I Recall
    • 9.6.6. Oct 02, 2013: Synergy Pharmaceuticals Announces Plans to Initiate a Phase 2 Study of SP-333 for Opioid-Induced Constipation
    • 9.6.7. Jun 25, 2013: nContact Continues To Expand Intellectual Property Portfolio For Its Multidisciplinary Approach For Treatment Of Cardiac Arrhythmias
  • 9.7. Strategy And Business Planning
    • 9.7.1. Sep 17, 2013: Medtronic Opens New Customer Innovation Centre in Galway, Ireland
    • 9.7.2. Sep 02, 2013: Medtronic announces formation of hospital solutions business aimed at driving efficiencies
    • 9.7.3. Aug 29, 2013: Medtronic To Set Up Global Center Of Excellence In Singapore For Business Model Innovation

10. Appendix

  • 10.1. Research Methodology
    • 10.1.1. Coverage
    • 10.1.2. Secondary Research
    • 10.1.3. Primary Research
    • 10.1.4. Market Modeling and Forecasting
    • 10.1.5. Company Share Analysis
    • 10.1.6. Distribution Share Analysis
  • 10.2. Expert Panel
  • 10.3. GlobalData Consulting
  • 10.4. Contact Us
  • 10.5. Disclaimer

List of Tables

  • Table 1: Cardiac Rhythm Management Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2005-2020
  • Table 2: Cardiac Rhythm Management Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-2020
  • Table 3: Cardiac Rhythm Management Market, North America, Revenue ($m), Historic, USD Constant, 2005-2012
  • Table 4: Cardiac Rhythm Management Market, North America, Revenue ($m), Forecast, USD Constant, 2012-2020
  • Table 5: Cardiac Rhythm Management Market, North America, Volume (Units), 2005-2020
  • Table 6: Cardiac Rhythm Management Market, North America, Volume (Units), Historic, 2005-2012
  • Table 7: Cardiac Rhythm Management Market, North America, Volume (Units), Forecast, 2012-2020
  • Table 8: Cardiac Rhythm Management Market, North America, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 9: Cardiac Rhythm Management Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 10: Cardiac Rhythm Management Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 11: Cardiac Resynchronisation Therapy Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 12: Implantable Cardioverter Defibrillators Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 13: Pacemakers Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 14: Cardiac Resynchronisation Therapy Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 15: Implantable Cardioverter Defibrillators Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 16: Pacemakers Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 17: Cardiac Rhythm Management Market, Canada, Volume (Units), Historic, 2005-2012
  • Table 18: Cardiac Rhythm Management Market, Canada, Volume (Units), Forecast, 2012-2020
  • Table 19: Cardiac Resynchronisation Therapy Market, Canada, Volume (Units), Historic, 2005-2012
  • Table 20: Implantable Cardioverter Defibrillators Market, Canada, Volume (Units), Historic, 2005-2012
  • Table 21: Pacemakers Market, Canada, Volume (Units), Historic, 2005-2012
  • Table 22: Cardiac Resynchronisation Therapy Market, Canada, Volume (Units), Forecast, 2012-2020
  • Table 23: Implantable Cardioverter Defibrillators Market, Canada, Volume (Units), Forecast, 2012-2020
  • Table 24: Pacemakers Market, Canada, Volume (Units), Forecast, 2012-2020
  • Table 25: Cardiac Rhythm Management Market, Canada, Average Price ($), Historic, 2005-2012
  • Table 26: Cardiac Rhythm Management Market, Canada, Average Price ($), Forecast, 2012-2020
  • Table 27: Cardiac Rhythm Management Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 28: Cardiac Rhythm Management Market, Canada, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 29: Cardiac Rhythm Management Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 30: Cardiac Rhythm Management Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 31: Cardiac Resynchronisation Therapy Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 32: Implantable Cardioverter Defibrillators Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 33: Pacemakers Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 34: Cardiac Resynchronisation Therapy Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 35: Implantable Cardioverter Defibrillators Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 36: Pacemakers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 37: Cardiac Rhythm Management Market, Mexico, Volume (Units), Historic, 2005-2012
  • Table 38: Cardiac Rhythm Management Market, Mexico, Volume (Units), Forecast, 2012-2020
  • Table 39: Cardiac Resynchronisation Therapy Market, Mexico, Volume (Units), Historic, 2005-2012
  • Table 40: Implantable Cardioverter Defibrillators Market, Mexico, Volume (Units), Historic, 2005-2012
  • Table 41: Pacemakers Market, Mexico, Volume (Units), Historic, 2005-2012
  • Table 42: Cardiac Resynchronisation Therapy Market, Mexico, Volume (Units), Forecast, 2012-2020
  • Table 43: Implantable Cardioverter Defibrillators Market, Mexico, Volume (Units), Forecast, 2012-2020
  • Table 44: Pacemakers Market, Mexico, Volume (Units), Forecast, 2012-2020
  • Table 45: Cardiac Rhythm Management Market, Mexico, Average Price ($), Historic, 2005-2012
  • Table 46: Cardiac Rhythm Management Market, Mexico, Average Price ($), Forecast, 2012-2020
  • Table 47: Cardiac Rhythm Management Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 48: Cardiac Rhythm Management Market, Mexico, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 49: Cardiac Rhythm Management Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 50: Cardiac Rhythm Management Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 51: Cardiac Resynchronisation Therapy Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 52: Implantable Cardioverter Defibrillators Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 53: Pacemakers Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 54: Cardiac Resynchronisation Therapy Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 55: Implantable Cardioverter Defibrillators Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 56: Pacemakers Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 57: Cardiac Rhythm Management Market, United States, Volume (Units), Historic, 2005-2012
  • Table 58: Cardiac Rhythm Management Market, United States, Volume (Units), Forecast, 2012-2020
  • Table 59: Cardiac Resynchronisation Therapy Market, United States, Volume (Units), Historic, 2005-2012
  • Table 60: Implantable Cardioverter Defibrillators Market, United States, Volume (Units), Historic, 2005-2012
  • Table 61: Pacemakers Market, United States, Volume (Units), Historic, 2005-2012
  • Table 62: Cardiac Resynchronisation Therapy Market, United States, Volume (Units), Forecast, 2012-2020
  • Table 63: Implantable Cardioverter Defibrillators Market, United States, Volume (Units), Forecast, 2012-2020
  • Table 64: Pacemakers Market, United States, Volume (Units), Forecast, 2012-2020
  • Table 65: Cardiac Rhythm Management Market, United States, Average Price ($), Historic, 2005-2012
  • Table 66: Cardiac Rhythm Management Market, United States, Average Price ($), Forecast, 2012-2020
  • Table 67: Cardiac Rhythm Management Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 68: Cardiac Rhythm Management Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 69: Cardiac Rhythm Management Market Pipeline Products
  • Table 70 Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

List of Figures

  • Figure 1: Cardiac Rhythm Management Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2005-2020
  • Figure 2: Cardiac Rhythm Management Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-2020
  • Figure 3: Cardiac Rhythm Management Market, North America, Revenue ($m), Historic, USD Constant, 2005-2012
  • Figure 4: Cardiac Rhythm Management Market, North America, Revenue ($m), Forecast, USD Constant, 2012-2020
  • Figure 5: Cardiac Rhythm Management Market, North America, Volume (Units), 2005-2020
  • Figure 6: Cardiac Rhythm Management Market, North America, Volume (Units), Historic, 2005-2012
  • Figure 7: Cardiac Rhythm Management Market, North America, Volume (Units), Forecast, 2012-2020
  • Figure 8: Cardiac Rhythm Management Market, North America, Company Share (%), 2012
  • Figure 9: Cardiac Rhythm Management Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 10: Cardiac Rhythm Management Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 11: Cardiac Resynchronisation Therapy Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 12: Implantable Cardioverter Defibrillators Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 13: Pacemakers Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 14: Cardiac Resynchronisation Therapy Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 15: Implantable Cardioverter Defibrillators Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 16: Pacemakers Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 17: Cardiac Rhythm Management Market, Canada, Volume (Units), Historic, 2005-2012
  • Figure 18: Cardiac Rhythm Management Market, Canada, Volume (Units), Forecast, 2012-2020
  • Figure 19: Cardiac Resynchronisation Therapy Market, Canada, Volume (Units), Historic, 2005-2012
  • Figure 20: Implantable Cardioverter Defibrillators Market, Canada, Volume (Units), Historic, 2005-2012
  • Figure 21: Pacemakers Market, Canada, Volume (Units), Historic, 2005-2012
  • Figure 22: Cardiac Resynchronisation Therapy Market, Canada, Volume (Units), Forecast, 2012-2020
  • Figure 23: Implantable Cardioverter Defibrillators Market, Canada, Volume (Units), Forecast, 2012-2020
  • Figure 24: Pacemakers Market, Canada, Volume (Units), Forecast, 2012-2020
  • Figure 25: Cardiac Rhythm Management Market, Canada, Company Share (%), 2012
  • Figure 26: Cardiac Rhythm Management Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 27: Cardiac Rhythm Management Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 28: Cardiac Resynchronisation Therapy Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 29: Implantable Cardioverter Defibrillators Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 30: Pacemakers Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 31: Cardiac Resynchronisation Therapy Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 32: Implantable Cardioverter Defibrillators Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 33: Pacemakers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 34: Cardiac Rhythm Management Market, Mexico, Volume (Units), Historic, 2005-2012
  • Figure 35: Cardiac Rhythm Management Market, Mexico, Volume (Units), Forecast, 2012-2020
  • Figure 36: Cardiac Resynchronisation Therapy Market, Mexico, Volume (Units), Historic, 2005-2012
  • Figure 37: Implantable Cardioverter Defibrillators Market, Mexico, Volume (Units), Historic, 2005-2012
  • Figure 38: Pacemakers Market, Mexico, Volume (Units), Historic, 2005-2012
  • Figure 39: Cardiac Resynchronisation Therapy Market, Mexico, Volume (Units), Forecast, 2012-2020
  • Figure 40: Implantable Cardioverter Defibrillators Market, Mexico, Volume (Units), Forecast, 2012-2020
  • Figure 41: Pacemakers Market, Mexico, Volume (Units), Forecast, 2012-2020
  • Figure 42: Cardiac Rhythm Management Market, Mexico, Company Share (%), 2012
  • Figure 43: Cardiac Rhythm Management Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 44: Cardiac Rhythm Management Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 45: Cardiac Resynchronisation Therapy Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 46: Implantable Cardioverter Defibrillators Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 47: Pacemakers Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 48: Cardiac Resynchronisation Therapy Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 49: Implantable Cardioverter Defibrillators Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 50: Pacemakers Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 51: Cardiac Rhythm Management Market, United States, Volume (Units), Historic, 2005-2012
  • Figure 52: Cardiac Rhythm Management Market, United States, Volume (Units), Forecast, 2012-2020
  • Figure 53: Cardiac Resynchronisation Therapy Market, United States, Volume (Units), Historic, 2005-2012
  • Figure 54: Implantable Cardioverter Defibrillators Market, United States, Volume (Units), Historic, 2005-2012
  • Figure 55: Pacemakers Market, United States, Volume (Units), Historic, 2005-2012
  • Figure 56: Cardiac Resynchronisation Therapy Market, United States, Volume (Units), Forecast, 2012-2020
  • Figure 57: Implantable Cardioverter Defibrillators Market, United States, Volume (Units), Forecast, 2012-2020
  • Figure 58: Pacemakers Market, United States, Volume (Units), Forecast, 2012-2020
  • Figure 59: Cardiac Rhythm Management Market, United States, Company Share (%), 2012
  • Figure 60: GlobalData Epidemiology-Based Forecasting Model
  • Figure 61: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 62: Primary Interviews by Participant Type (%)
Back to Top